Monday, April 14, 2025
8:30 - 9:00 am
Registration and Breakfast
Lobby, 2nd Floor, Berg Hall, LKSC Building
9:00 - 9:10 am
WELCOME AND OPENING REMARKS
William Greenleaf, Ph.D.
Director, RNA Medicine Program
Professor of Genetics
Stanford University School of Medicine
9:10 - 9:50 am
OPENING KEYNOTE
Moderated by William Greenleaf, Ph.D.
Drew Weissman, M.D., Ph.D.
Director, Penn Institute for RNA Innovation
Roberts Professor of Vaccine Research
University of Pennsylvania
Nucleoside-Modified mRNA-LNP Therapeutics
9:50 – 10:50 am
SESSION 1: RNA THERAPEUTICS
9:50 – 10:10 am
William Robinson, M.D., Ph.D.
James W. Raitt, M.D. Professor
Division Chief, Immunology & Rheumatology
Stanford University School of Medicine
EBV in Autoimmune Disease
10:10 – 10:30 am
Fyodor Urnov, Ph.D.
Professor, Molecular Therapeutics
Scientific Director, Innovative Genomics Institute (IGI)
University of California, Berkeley
RNA Medicines On-Demand in CRISPR Space: a Gene-Editing Platform for Inborn Errors of Immunity
10:30 – 10:50 am
Howard Y. Chang, M.D., Ph.D.
CSO, Amgen
Xist RNP in female biased autoimmunity
10:50 - 11:10 am
Coffee Break
11:10 – 12:10 pm
SESSION 1: RNA THERAPEUTICS - CONT.
11:10 – 11:30 am
Ravi Majeti, M.D., Ph.D.
Virginia and D.K. Ludwig Professor
Professor of Medicine (Hematology)
Director, Institute for Stem Cell Biology and Regenerative Medicine
Stanford University School of Medicine
Reprogramming Cancer into Antigen Presenting Cells for Cancer Vaccination
11:30 – 11:50 am
Bali Pulendran, Ph.D.
Professor, Pathology, Microbiology & Immunology
Director, Institute for Immunity, Transplantation & Infection
Stanford University School of Medicine
Systems biological assessment of human immunity to vaccination
11:50 – 12:10 pm
Robert Waymouth, Ph.D.
Robert Eckles Swain Professor of Chemistry and Professor, by courtesy, of Chemical Engineering
New materials for RNA delivery: How to get it where it needs to go
Poster-Teaser
12:10 - 1:30 pm
Lunch
1:10 – 1:25 pm
INDUSTRY SPONSORED TALK
Devan Shah
Founder & CEO, RNAV8 Bio
mRNA Engineering Redefined
1:30 – 2:50 pm
SESSION 2: AI AND COMPUTATIONAL TECHNOLOGY
1:30 – 1:50 pm
Liana Lareau, Ph.D.
Assistant Professor, Bioengineering
University of California, Berkeley
Deep learning and deep sequencing for RNA design
1:50 – 2:10 pm
Le Cong, Ph.D.
Assistant Professor, Pathology & Genetics
Stanford University School of Medicine
Accelerating RNA Medicines with CRISPR-GPT AI Agents integrating Expert LLMs and RNA Foundation Models
2:10 – 2:30 pm
Stephen Quake, Ph.D.
Lee Otterson Professor, School of Engineering
Professor, Bioengineering, Applied Physics, and by Courtesy, Physics
Head of Science, Chan Zuckerberg Initiative
Stanford University
A Decade of Molecular Cell Atlases
2:30 – 2:50 pm
William Greenleaf, Ph.D.
Director, RNA Medicine Program
Professor of Genetics
Stanford University School of Medicine
Scaling quantitative measurements of RNA function
2:50 - 3:10 pm
Coffee Break
3:10 – 4:10 pm
SESSION 3: RNA TECHNOLOGY
3:10 – 3:30 pm
Ryan Flynn, M.D., Ph.D.
Principal Investigator, Flynn Lab
Assistant Professor, Stem Cell & Regenerative Biology, Harvard University
Cell surface glycoRNA biology
3:30 – 3:50 pm
Eric T. Kool, Ph.D.
George & Hilda Daubert Professor of Chemistry
Stanford University
Profiling the transcriptome interactions of drugs of unknown target
3:50 – 4:10 pm
Felix Horns, Ph.D.
Core Investigator, Arc Institute
Assistant Professor, Department of Genetics
Stanford University School of Medicine
Harnessing RNA export to monitor and manipulate living cells
4:10 – 4:50 pm
CLOSING KEYNOTE
Moderated by William Greenleaf, Ph.D.
Carolyn Bertozzi, Ph.D.
Baker Family Director, Sarafan ChEM-H
Investigator, Howard Hughes Medical Institute
Professor of Chemistry, Stanford University
Therapeutic opportunities in glycoscience
Poster-Teaser
5:00 – 6:30 pm
POSTER SESSION AND DRINK RECEPTION